Artificial Intelligence Applied to in vitro Gene Expression Testing (IVIGET) to Predict Trivalent Inactivated Influenza Vaccine Immunogenicity in HIV Infected Children-Reference-Cited by-同舟云学术

Artificial Intelligence Applied to in vitro Gene Expression Testing (IVIGET) to Predict Trivalent Inactivated Influenza Vaccine Immunogenicity in HIV Infected Children

Published:2020-10-05 Issue: Volume:11 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Cotugno Nicola,Santilli Veronica,Pascucci Giuseppe Rubens,Manno Emma Concetta,De Armas Lesley,Pallikkuth Suresh,Deodati Annalisa,Amodio Donato,Zangari Paola,Zicari Sonia,Ruggiero Alessandra,Fortin Martina,Bromley Christina,Pahwa Rajendra,Rossi Paolo,Pahwa Savita,Palma Paolo

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference46 articles.

1. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States;Roush;JAMA,2007

2. Local health department costs associated with response to a school-based pertussis outbreak — Omaha, Nebraska, September-November 200859MMWR Morb Mortal Wkly Rep.602011

3. Immune reconstitution and vaccination outcome in HIV-1 infected children: present knowledge and future directions;Cagigi;Hum Vaccin Immunother,2012

4. Suboptimal immune reconstitution in vertically HIV infected children: a view on how HIV replication and timing of HAART initiation can impact on T and B-cell compartment;Cotugno;Clin Dev Immunol,2012

5. OMIC technologies and vaccine development: from the identification of vulnerable individuals to the formulation of invulnerable vaccines;Cotugno;J Immunol Res,2019

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Children with perinatally acquired HIV exhibit distinct immune responses to 4CMenB vaccine;JCI Insight;2024-04-11

2. Modeling human immune responses to vaccination in vitro;Trends in Immunology;2024-01

3. The omics strategy: the use of systems vaccinology to characterize immune responses to childhood immunization;Expert Review of Vaccines;2022-07-05

4. HUMORAL AND CELLULAR IMMUNOGENICITY and SAFETY UP TO 4 MONTHS AFTER VACCINATION WITH BNT162B2 mRNA COVID-19 VACCINE IN HEART AND LUNG TRANSPLANTED YOUNG ADULTS;2021-09-22

5. Virological and immunological features of SARS‐COV‐2 infected children with distinct symptomatology;Pediatric Allergy and Immunology;2021-07-16